Propranolol glucuronide
IMPURITIES
![]() |
Buyer Protection |
![]() ![]() |
|
Product Details |
|
CAT No.# | CS-Y-00126 |
Category | Impurities |
CAS | 66322-66-5 |
Molecular Weight | 435.47 |
Molecular Formula | C22H29NO8 |
Synonyms: | (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((1-(isopropylamino)-3-(naphthalen-1-yloxy)propan-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
Shipping: | Free Shipping for worldwide on order above 2000 USD |
COA / MSDS: | View COA MSDS |
The balance used are calibrated with weights traceable to National Standards NIST for accuracy |
Related Results for 'Propranolol glucuronide'
-
API Standards of Propranolol
-
Stable Isotopes of Propranolol
-
Metabolites of Propranolol
-
Impurities of Propranolol
-
Glucuronides of Propranolol
-
Intermediates of Propranolol
Propranolol glucuronide
Worldwide Suppliers of Propranolol glucuronide
https://www.clearsynth.com/en/CSY00126.html
Impurities
Clearsynth
CS-Y-00126
PEOPLE
ALSO SEARCHED FOR:
1.
propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylateProduct rating: 9 Propranolol glucuronide based on 20 ratings
$912
In stock
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)
This page contains information about Propranolol glucuronide Cas 66322-66-5 and its Impurities.
Propranolol glucuronide Propranolol glucuronide Impurities of Propranolol glucuronide https://www.clearsynth.com/en/CSY00126.html Impurities Clearsynth 66322-66-5 mg https://www.clearsynth.com/en/temp/CS-Y-00126.jpg
"Products currently covered
by valid US Patents are offered for R&D use in accordance with
35 USC 271(e)+A13(1). Any patent infringement and resulting
liability is solely at buyer risk."